AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE751.00-5.25 (-0.69 %)
PREV CLOSE ( ) 756.25
OPEN PRICE ( ) 754.20
BID PRICE (QTY) 751.10 (43)
OFFER PRICE (QTY) 751.70 (23)
VOLUME 148995
TODAY'S LOW / HIGH ( )741.00 765.70
52 WK LOW / HIGH ( )527.05 826.35
NSE751.90-4.4 (-0.58 %)
PREV CLOSE( ) 756.30
OPEN PRICE ( ) 755.95
BID PRICE (QTY) 751.75 (41)
OFFER PRICE (QTY) 751.90 (89)
VOLUME 1697933
TODAY'S LOW / HIGH( ) 740.20 765.65
52 WK LOW / HIGH ( )527 827.45
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
11Oct Aurobindo Pharma receives USFDA’s nod
Aurobindo Pharma has received final approval from the US Food & Drug..
18Sep Aurobindo Pharma receives approval fro
Aurobindo Pharma has received approval from the South African Health Pro..
06Sep Aurobindo Pharma’s arm inks agreement
Aurobindo Pharma’s wholly owned subsidiary -- Aurobindo Pharma USA Inc.,..
06Sep Aurobindo Pharma surges with arm inkin
Aurobindo Pharma is currently trading at Rs. 720.25, up by 24.15 points..
31Aug Shareholder Meeting / Postal Ballot-O
Sub: Proceedings of 31st Annual General Meeting (AGM), Voting Results an..
Financials
Rs. in Millions
QTR Jun 18 ANNUAL 18
Net Profit2251.218127.7
Gross Profit 2820.5 23429.4
Operating Profit 3995.827506.6
Net Sales 25588.2103031.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7341.10 (0.36%)
M.Cap (Rs. in Cr)15599.33
Biocon (BSE)
 656.65 (3.19%)
M.Cap (Rs. in Cr)39429.00
Mercury Laboratories (BSE)
 419.90 (4.97%)
M.Cap (Rs. in Cr)50.39
Sanofi India (BSE)
 5935.00 (0.32%)
M.Cap (Rs. in Cr)13700.46
Neuland Laboratories (BSE)
 585.00 (2.27%)
M.Cap (Rs. in Cr)750.55
Shareholding Pattern
PROMOTERS 51.87%
MUTUAL FUNDS/UTI 14.53%
NON-INSTITUTION 13.98%
FI/BANKS/INSURANCE 0.51%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal,Apurva Mittal, Tel no: 022-40790032,022 - 40790024, Mobile no- 9773104340,9768009000 E-mail id- Complaince@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.